Chronic inflammatory disease and osteopathy: A systematic review

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Cicchitti, Luca ^a,b   Martelli, Marta ^a,b   Cerritelli, Francesco ^a,c  

^a Clinical based Human Research Department COME Collaboration   (Italy)

^b AIOT Accademia Italiana Osteopatia Tradizionale   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTHRITIS; ASTHMA; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; INFLAMMATORY DISEASE; INTENTION TO TREAT ANALYSIS; IRRITABLE COLON; MANIPULATIVE MEDICINE; META ANALYSIS; NONHUMAN; OBSERVATIONAL STUDY; OSTEOPATHIC MEDICINE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; REVIEW; SHAM PROCEDURE; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS; ANIMAL; BONE DISEASES; CHRONIC DISEASE; INFLAMMATION; IRRITABLE BOWEL SYNDROME; METABOLISM; PATHOLOGY; PERIPHERAL ARTERIAL DISEASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

RATTUS;

ANIMALS; ASTHMA; BONE DISEASES; CHRONIC DISEASE; HUMANS; INFLAMMATION; IRRITABLE BOWEL SYNDROME; PERIPHERAL ARTERIAL DISEASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RATS;

EID: 84925062133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121327     Document Type: Review

References (38)

1. nd edition. Philadelphia: Elsevier Saunders; 2007.
2. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases. JAMA. 2004; 291: 2616-22. PMID: 15173153
3. Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep. 2004; 119: 263-70. PMID: 15158105
4. Epstein FH, Barnes PJ, Karin M. Nuclear factor-êB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336: 1066-71. PMID: 9091804
5. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998; 115: 182-205. PMID: 9649475
6. Willoughby DA, Moore AR, Colville-Nash PR. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet. 2000; 355: 646-8. PMID: 10696997
7. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003; 3: 521-33. PMID: 12876555
8. Bosma-den Boer MM, van Wetten M-L, Pruimboom L. Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering. Nutr Metab (Lond). 2012; 9: 1-14.
9. Heap GA, van Heel DA. The genetics of chronic inflammatory diseases. Hum Mol Genet. 2009; 18: R101-R6. doi: 10.1093/hmg/ddp001 PMID: 19297396
10. Saydah SH, Eberhardt MS. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Altern Complement Med. 2006; 12: 805-12. PMID: 17034287
11. Ding R-B, Tian K, He C-W, Jiang Y, Wang Y-T, Wan J-B. Herbal medicines for the prevention of alcoholic liver disease: A review. J Ethnopharmacol. 2012; 144: 457-65. doi: 10.1016/j.jep.2012.09.044 PMID: 23058988
12. Zatalia S, Sanusi H. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta Med Indones. 2013; 45: 141-7. PMID: 23770795
13. Standley PR, Meltzer K. In vitro modeling of repetitive motion strain and manual medicine treatments: potential roles for pro- and anti-inflammatory cytokines. J Bodyw Mov Ther. 2008; 12: 201-3. doi: 10.1016/j.jbmt.2008.05.006 PMID: 19083676
14. Hicks MR, Cao TV, Campbell DH, Standley PR. Mechanical strain applied to human fibroblasts differentially regulates skeletal myoblast differentiation. J Appl Physiol (1985). 2012; 113: 465-72. doi: 10.1152/japplphysiol.01545.2011 PMID: 22678963
15. Licciardone JC, Kearns CM, Hodge LM, Bergamini MV. Associations of cytokine concentrations with key osteopathic lesions and clinical outcomes in patients with nonspecific chronic low back pain: results from the OSTEOPATHIC Trial. J Am Osteopath Assoc. 2012; 112: 596-605. PMID: 22984233
16. Cao TV, Hicks MR, Campbell D, Standley PR. Dosed myofascial release in three-dimensional bioengineered tendons: effects on human fibroblast hyperplasia, hypertrophy, and cytokine secretion. J Manipulative Physiol Ther. 2013; 36: 513-21. doi: 10.1016/j.jmpt.2013.07.004 PMID: 24047879
17. Henley CE, Ivins D, Mills M, Wen FK, Benjamin BA. Osteopathic manipulative treatment and it's relationship to autonomic nervous system activity as demonstrated by heart rate variability: a repeated measures study. Osteopath Med Prim Care. 2008; 2: 7. doi: 10.1186/1750-4732-2-7 PMID: 18534024
18. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Oxford: The Cochrane Collaboration; 2011. [Version 5.1.0 (updated March 2011)]
19. Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &Sons Ltd; 2008. pp. 187-241.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-60. PMID: 12958120
21. Bockenhauer SE, Julliard KN, Lo KS, Huang E, Sheth AM. Quantifiable effects of osteopathic manipulative techniques on patients with chronic asthma. J Am Osteopath Assoc. 2002; 102: 371-5. PMID: 12138951
22. Guiney PA, Chou R, Vianna A, Lovenheim J. Effects of osteopathic manipulative treatment on pediatric patients with asthma: a randomized controlled trial. J Am Osteopath Assoc. 2005; 105: 7-12. PMID: 15710659
23. Noll DR, Johnson JC, Baer RW, Snider EJ. The immediate effect of individual manipulation techniques on pulmonary function measures in persons with chronic obstructive pulmonary disease. Osteopath Med Prim Care. 2009; 3: 9. doi: 10.1186/1750-4732-3-9 PMID: 19814829
24. Zanotti E, Berardinelli P, Bizzarri C, Civardi A, Manstretta A, Rossetti S, et al. Osteopathic manipulative treatment effectiveness in severe chronic obstructive pulmonary disease: a pilot study. Complement Ther Med. 2012; 20: 16-22. doi: 10.1016/j.ctim.2011.10.008 PMID: 22305244
25. Attali TV, Bouchoucha M, Benamouzig R. Treatment of refractory irritable bowel syndrome with visceral osteopathy: short-term and long-term results of a randomized trial. J Dig Dis. 2013; 14: 654-61. doi: 10.1111/1751-2980.12098 PMID: 23981319
26. Hundscheid HW, Pepels MJ, Engels LG, Loffeld RJ. Treatment of irritable bowel syndrome with osteopathy: results of a randomized controlled pilot study. J Gastroenterol Hepatol. 2007; 22: 1394-8. PMID: 17716344
27. Lombardini R, Marchesi S, Collebrusco L, Vaudo G, Pasqualini L, Ciuffetti G, et al. The use of osteopathic manipulative treatment as adjuvant therapy in patients with peripheral arterial disease. Man Ther. 2009; 14: 439-43. doi: 10.1016/j.math.2008.08.002 PMID: 18824395
28. Florance BM, Frin G, Dainese R, Nebot-Vivinus MH, Marine Barjoan E, Marjoux S, et al. Osteopathy improves the severity of irritable bowel syndrome: a pilot randomized sham-controlled study. Eur J Gastroenterol Hepatol. 2012; 24: 944-9. doi: 10.1097/MEG.0b013e3283543eb7 PMID: 22546751
29. Hallas B, Lehman S, Bosak A, Tierney S, Galler R, Jacovina P, et al. Establishment of behavioral parameters for the evaluation of osteopathic treatment principles in a rat model of arthritis. J Am Osteopath Assoc. 1997; 97: 207-14. PMID: 9154739
30. Noll DR, Degenhardt BF, Johnson JC, Burt SA. Immediate effects of osteopathic manipulative treatment in elderly patients with chronic obstructive pulmonary disease. J Am Osteopath Assoc. 2008; 108: 251-9. PMID: 18519835
31. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012; 11: Mr000030. doi: 10.1002/14651858.MR000030.pub2 PMID: 23152285
32. Hopewell S, Collins GS, Boutron I, Yu LM, Cook J, Shanyinde M, et al. Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study. BMJ. 2014; 349: g4145. doi: 10.1136/bmj.g4145 PMID: 24986891
33. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990; 263: 1385-9. PMID: 2406472
34. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull. 1979; 86: 638.
35. Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, et al. Should unpublished data be included in meta-analyses?: Current convictions and controversies. JAMA. 1993; 269: 2749-53. PMID: 8492400
36. Dickersin K, Chan S, Chalmersx T, Sacks H, Smith H Jr. Publication bias and clinical trials. Control Clin Trials. 1987; 8: 343-53. PMID: 3442991
37. Grégoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol. 1995; 48: 159-63. PMID: 7853041
38. Moher D, Fortin P, Jadad AR, Jüni P, Klassen T, Le Lorier J, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet. 1996; 347: 363-6. PMID: 8598702